|
Product Details:
Payment & Shipping Terms:
|
Name: | Racecadotril | Appearance: | White Powder |
---|---|---|---|
CAS: | 81110-73-8 | Package: | Aluminum Foil Bag |
Production Capacity: | 500 Kilogram/month | Storage: | Kept In A Cool,dry And Ventilated Place |
Purity: | 99% | MF: | C21H23NO4S |
High Light: | Cas 81110-73-8 Plant Extract Powder,C21H23NO4S Racecadotril Powder,99% Purity Racecadotril Powder |
Racecadotril cas 81110-73-8 High Quality Racecadotril Competitive Price Racecadotril GMP Manufacturer
Product Name | Racecadotril |
CAS. | 81110-73-8 |
Molecular Weight | 385.48 |
Molecular Formula | C21H23NO4S |
EINECS | 688-010-7 |
Melting point | 89°C |
Storage temp | Refrigerator |
Form | powder |
Color | white to tan |
Package | Discreet Packing ways for your choice |
Delivery | Deliver out within 24 hours after payment |
Payment | Western Union, Money Gram. Bank Transfer |
Description
Racecad Unlike other opioid medications used to treat diarrhea, which reduce intestinal motility, racecadotril has an antisecretory effect - it reduces the secretion of water and electrolytes into the intestine. It is available in France (where it was first introduced in ~1990) and other European countries (including Germany, Italy, the United Kingdom, Spain, Russia and the Czech Republic) as well as most of South America and some South East Asian countries (including China, India and Thailand), but not in the United States. It is sold under the tradename Hidrasec, among others. Thiorphan is the active metabolite of racecadotril, which exerts the bulk of its inhibitory actions on enkephalinases.
Racecadotril is used for the treatment of acute diarrhea in children and adults and has better tolerability than loperamide, as it causes less constipation and flatulence. Several guidelines have recommended racecadotril use in addition to oral rehydration treatment in children with acute diarrhea.
Racecadotril has no contraindications apart from known hypersensitivity to the substance.
There is insufficient data for the therapy of chronic diarrhea, for patients with renal or hepatic failure, and for children under three months. Additional contraindications for the children's formulation are hereditary fructose intolerance, glucose-galactose malabsorption and saccharase deficiency, as it contains sugar.
The most common adverse effect is headache, which occurs in 1-2% of patients.Rashes occur in fewer than 1% of patients. Other described skin reactions include itching, urticaria, angioedema, erythema multiforme, and erythema nodosum.
Contact Person: July
Tel: 25838890